Meeting
2016 ASCO Annual Meeting
Genetic heterogeneity of KRAS-mutated NSCLC: Co-occurrence of potentially targetable aberrations and evolutionary background.
Authors
Matthias Scheffler
Lung Cancer Group Cologne, Department I of Internal Medicine and Center for Integrated Oncology Cologne Bonn, University Hospital Cologne, Cologne, Germany
Matthias Scheffler , Michaela A. Ihle , Rebecca Hein , Sabine Merkelbach-Bruse , Johannes Braegelmann , Andreas H. Scheel , Sebastian Yves Friedrich Michels , Frank Ueckeroth , Anna Eisert , Leonie Gogl , Rieke Frank , Rieke Nila Fischer , Sophia Koleczko , Carsten Schaepers , Anna Kostenko , Florian Kron , Martin Hellmich , Martin L. Sos , Reinhard Buettner , Juergen Wolf
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 9018)
DOI
10.1200/JCO.2016.34.15_suppl.9018
Abstract #
9018
Poster Bd #
341
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.
First Author: Daniela Adua
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2020 Gastrointestinal Cancers Symposium
Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.
First Author: Michael C. Burns
Poster
2014 ASCO Annual Meeting
Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.
First Author: Lindsay Carol Overton